SignIn
Kerala Kaumudi Online
Saturday, 13 August 2022 2.27 PM IST

First Covid nasal vaccine in country; trial completed successfully, says Bharat Biotech

nasal-vaccine

NEW DELHI: Bharat Biotech has successfully completed the third phase of the trial for Covid nasal vaccine. The company said it would submit the test results to the DCGI (Drug Controller General of India) next month.

‘The information is being analysed. The test results will be submitted to the DCGI shortly. If approved, it will be the world's first proven nasal Covid vaccine,’ said Dr Krishna Ella, Chairman and MD, Bharat Biotech.

The DCGI approved the third phase of testing for nasal vaccine in last January. The indications are that this vaccine is capable of resisting newer Covid variants such as Omicron.


Bharat Biotech is the second company in India to apply for the third phase trial of Covid vaccine. Krishna Ella said that those who have taken the two doses of vaccine must take the booster dose and the third dose will give better immunity.

JOIN THE DISCUSSION
TAGS: FIRST COVID, NASAL VACCINE, COUNTRY, TRIAL COMPLETED, SUCCESSFULLY, BHARAT BIOTECH
KERALA KAUMUDI EPAPER
TRENDING IN INDIA
TRENDING IN INDIA
X
Lorem ipsum dolor sit amet
consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
We respect your privacy. Your information is safe and will never be shared.